The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Side-effect management › Pre-existing rheumatologic conditions › Reply To: Pre-existing rheumatologic conditions
January 5, 2018 at 2:50 am #4598
Expert NurseVirginia Seery
Great question Lisa! Our approach to this issue follows Krista’s guidelines with each particular patient’s situation evaluated independently weighing the risks and benefits. Several years ago we would have avoided I/O therapy in patients with autoimmune conditions, but that practice has now changed as more information has come out showing that it can be offered to some patients.